Distolingual Infiltration Verses Conventional Nerve Block in Mandibular Third Molar Extraction
NCT ID: NCT07296926
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2024-08-15
2026-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Conventional Buccal Nerve Block Versus Buccal Nerve Trunk Block During Extraction of Posterior Mandibular Teeth
NCT07330518
Comparison of Intraligamentary Anesthesia With the Inferior Alveolar Nerve Block for the Extraction of Mandibular Molars.
NCT06611865
Comparison Between Efficiency of Inferior Alveolar Nerve Block and Buccal Infiltration Techniques Using Articaine 4% 1:100000
NCT03130855
Buccal Infiltration Anesthesia Versus Inferior Alveolar Nerve Block Anesthesia
NCT05221190
Postoperative Pain and Swelling After Flap vsFlapless Technique For Mandibular Third Molar Surgery
NCT07247929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled trial will enroll 120 patients requiring mandibular third molar extraction. Participants will be randomized into two groups: conventional inferior alveolar and buccal nerve block (Group A) and the same technique with additional distolingual infiltration (Group B). Pain during mucoperiosteal flap elevation and bone guttering will be recorded on a 0-10 Visual Analogue Scale. The primary objective is to determine whether distolingual infiltration improves pain control compared to the conventional technique.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
conventional nerve block injection
Inferior alveolar and buccal nerve block using 2% lignocaine with adrenaline (1:80,000) without distolingual infiltration.
Conventional Inferior Alveolar and Buccal Nerve Block
Standard inferior alveolar and long buccal nerve block for mandibular third molar extraction.
conventional inferior alveolar with distolingual infilterate injection
Inferior alveolar supplemented with distolingual infiltration using 2% lignocaine with adrenaline (1:80,000).
Distolingual Infiltration plus Conventional Nerve Block
Distolingual infiltration (0.2 ml) administered in addition to conventional inferior alveolar during mandibular third molar extraction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional Inferior Alveolar and Buccal Nerve Block
Standard inferior alveolar and long buccal nerve block for mandibular third molar extraction.
Distolingual Infiltration plus Conventional Nerve Block
Distolingual infiltration (0.2 ml) administered in addition to conventional inferior alveolar during mandibular third molar extraction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and female
* Age 18-45 years
* Mandibular third molar impaction - all positions
* Mandibular third molar impaction - all classes
Exclusion Criteria
* Patients requiring multiple extractions in the same appointment
* Allergy to lignocaine
* Patients in whom adrenaline is contraindicated
* Medically compromised individuals e.g. poorly controlled diabetes, hypertension
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Watim Medical & Dental College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
aimen zafar
prinicpal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Aimen Zafar
Islamabad, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DSG-2023-335-4631-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.